169 related articles for article (PubMed ID: 29556354)
21. Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS.
Park JJ; Park BK
J Magn Reson Imaging; 2017 Jun; 45(6):1753-1759. PubMed ID: 27783436
[TBL] [Abstract][Full Text] [Related]
22. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
23. Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
Habibian DJ; Liu CC; Dao A; Kosinski KE; Katz AE
AJR Am J Roentgenol; 2017 Mar; 208(3):564-569. PubMed ID: 28075651
[TBL] [Abstract][Full Text] [Related]
24. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
Tan N; Margolis DJ; Lu DY; King KG; Huang J; Reiter RE; Raman SS
AJR Am J Roentgenol; 2015 Jul; 205(1):W87-92. PubMed ID: 26102423
[TBL] [Abstract][Full Text] [Related]
27. Detection of prostate cancer index lesions with multiparametric magnetic resonance imaging (mp-MRI) using whole-mount histological sections as the reference standard.
Russo F; Regge D; Armando E; Giannini V; Vignati A; Mazzetti S; Manfredi M; Bollito E; Correale L; Porpiglia F
BJU Int; 2016 Jul; 118(1):84-94. PubMed ID: 26198404
[TBL] [Abstract][Full Text] [Related]
28. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
[TBL] [Abstract][Full Text] [Related]
29. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
[TBL] [Abstract][Full Text] [Related]
30. Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.
Tamada T; Sone T; Kanomata N; Miyaji Y; Kido A; Jo Y; Yamamoto A; Ito K
J Magn Reson Imaging; 2016 Sep; 44(3):584-93. PubMed ID: 26872679
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
32. Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria.
Almeida GL; Petralia G; Ferro M; Ribas CA; Detti S; Jereczek-Fossa BA; Matei DV; Coman I; De Cobelli O; Tagliabue E
Urol Int; 2016; 96(4):459-69. PubMed ID: 27045167
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.
Augustin H; Graefen M; Palisaar J; Blonski J; Erbersdobler A; Daghofer F; Huland H; Hammerer PG
J Clin Oncol; 2003 Aug; 21(15):2860-8. PubMed ID: 12885802
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
[TBL] [Abstract][Full Text] [Related]
35. Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer.
Pellinen T; Sandeman K; Blom S; Turkki R; Hemmes A; Välimäki K; Eineluoto J; Kenttämies A; Nordling S; Kallioniemi O; Rannikko A; Mirtti T
Cancer Res Commun; 2022 Mar; 2(3):172-181. PubMed ID: 36874403
[TBL] [Abstract][Full Text] [Related]
36. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
37. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
[TBL] [Abstract][Full Text] [Related]
38. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
39. Preoperative evaluation of pelvine lymph node metastasis in high risk prostate cancer with intravoxel incoherent motion (IVIM) MRI.
Sauer M; Klene C; Kaul M; Quitzke A; Avanesov M; Behzadi C; Budäus L; Beyersdorff D; Adam G; Regier M
Eur J Radiol; 2018 Oct; 107():1-6. PubMed ID: 30292252
[TBL] [Abstract][Full Text] [Related]
40. Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer.
Porpiglia F; Russo F; Manfredi M; Mele F; Fiori C; Regge D
Int Braz J Urol; 2015; 41(1):124-33. PubMed ID: 25928518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
